探讨达芬奇机器人辅助子宫内膜癌全面分期手术并发症的发生情况及危险因素。方法：回顾 性分析 2014 年 10 月 ~2019 年 6 月郑州大学第一附属医院收治的达芬奇机器人辅助子宫内膜癌全面分期手术患者的 临床资料，单因素分析采用χ 2 检验或 Wilcoxon 秩和检验法，将单因素分析中差异有统计学意义的变量纳入多因素 Logistic 回归分析。结果：279 例患者中，53 例（19.0%）发生并发症，其中术中并发症 5 例（1.8%），包括输尿管 损伤 2 例（0.7%）、血管损伤 3 例（1.1%），术后并发症 48 例（17.2%），包括深静脉血栓形成 17 例（6.1%）、 肺栓塞 5 例（1.8%）、肠梗阻 3 例（1.1%）、发热 8 例（2.9%）、淋巴潴留囊肿 7 例（2.5%）、盆腔脓肿 6 例（2.2%）、 乳糜漏 2 例（0.7%）。单因素分析结果显示达芬奇机器人辅助子宫内膜癌全面分期手术并发症的发生与患者年龄、 术中出血量、手术时间及合并糖尿病有关（P<0.05），多因素分析结果显示年龄 >60 岁（OR=3.083，95% CI： 1.545~6.154，P=0.001）、手术时间 >180min（OR=2.091，95% CI：1.053~4.153，P=0.035）以及术中出血量 >200ml （OR=3.617，95% CI：1.018~12.848，P=0.047）是达芬奇机器人辅助子宫内膜癌全面分期手术术中及术后总体并 发症发生的独立危险因素。多因素分析结果显示，年龄 >60 岁（OR=3.712，95% CI：1.359~10.137，P=0.011）、 肥 胖（OR=2.004，95% CI：1.027~3.908，P=0.041）、 术 中 出 血 量 >200ml（OR=7.033，95% CI：1.704~29.026， P=0.007）是发生 Clavien-Dindo Ⅱ级及以上术后并发症的独立危险因素。结论：达芬奇机器人子宫内膜癌术后并发 症 Clavien-Dindo 分级多为Ⅰ级和Ⅱ级，年龄 >60 岁、手术时间 >3h 及术中出血量 >200ml 是达芬奇机器人辅助子宫 内膜癌全面分期手术总体并发症发生的预测因素。年龄 >60 岁、肥胖、术中出血量 >200ml 是发生 Clavien-Dindo Ⅱ 级及以上术后并发症的预测因素。

To study the incidence and risk factors of perioperative complications in Da Vinci robotic-assisted comprehensive staging surgery on treating endometrial cancer. Methods: The clinical data of patients with endometrial cancer underwent Da Vinci robotic-assisted comprehensive staging surgery from October 2014 to June 2019 in the First Affiliated Hospital of Zhengzhou University were retrospectively analyzed. Univariate analysis was performed with χ 2 test or the Wilcoxon rank sum test. The statistically significant variables were included in multivariate logistic regression analysis to identify risk factors of complications. Results: 279 cases in total were selected into this study, among which 53 cases (19.0%) found complications. 5 cases (1.8%) of intraoperative complications, 2 cases (0.7%) of ureteral injury and 3 cases (1.1%) of vascular injury were found in the 53 cases. 17 cases (6.1%) of deep vein thrombosis, 5 cases (1.8%) of pulmonary embolism, 3 cases (1.1%) of ileus, 8 cases (2.8%) of fever, 7 cases (2.5%) of lymphocele, 6 cases (2.2%) of pelvic abscess and 2 cases (0.7%) of chylous fistula were found in 48 cases (17.2%) of postoperative complications. Univariate analysis shows that age, intraoperative blood loss and operation time are related to the incidence of complications (P<0.05). Multivariate analysis shows that patients’ age >60 years (OR=3.083, 95% CI: 1.545-6.154, P=0.001), operative time >180 min (OR=2.091, 95% CI: 1.053-4.153, P=0.035) and intraoperative blood loss >200 ml (OR=3.617, 95% CI: 1.018-12.848, P=0.047) are risk factors to occurrence of complications. Multivariate analysis suggests that patients’ age >60 years (OR=3.712, 95% CI: 1.359-10.137, P=0.011), obesity (OR=2.004, 95% CI: 1.027-3.908, P=0.041) and intraoperative blood loss >200 ml (OR=7.033, 95% CI: 1.704-29.026, P=0.007) are risk factors to Clavien-Dindo grade II or higher grade of postoperative complications. Conclusion: Most postoperative complications were Clavien-Dindo grade I or II in robotic-assisted comprehensive staging surgery on treating endometrial cancer. Patients’ age > 60 years, operative time >180 min and intraoperative blood loss >200 ml are predictors of complications after robotic-assisted comprehensive staging surgery on treating endometrial cancer. Patients’ age >60 years, obesity and intraoperative blood loss > 200ml are predictors for Clavien-Dindo grade II or higher grade of postoperative complications.

收稿日期：2020-03-10  录用日期：2020-05-25 

Received Date: 2020-03-10  Accepted Date: 2020-05-25 

基金项目：河南省医学科技攻关计划联合共建项目（LHG 20190122） 

Foundation Item: Medical science and technology research plan joint construction project of Henan Province (LHG 20190122) 

通讯作者：纪妹，Email：jimei0821@163.com Corresponding Author: JI Mei, Email: jimei0821@163.com 

引用格式：李喆，纪妹，赵曌，等 . 机器人辅助子宫内膜癌全面分期手术并发症危险因素分析 [J]. 机器人外科学杂志，2020，1（4）： 271-279. 

Citation: LI Z, JI M, ZHAO Z, et al. Analysis on risk factors of complications in robotic-assisted comprehensive staging surgery on treating endometrial cancer[J]. Chinese Journal of Robotic Surgery, 2020, 1 (4):271-279.

[1] Burke W M, Orr J, Leitao M, et al. Endometrial cancer: a review and current management strategies: part I[J]. Gynecol Oncol, 2014, 134(2): 385-392. 

[2] Diaz-Arrastia C, Jurnalov C, Gomez G, et al. Laparoscopic hysterectomy using a computer-enhanced surgical robot[J]. Surg Endosc, 2002, 16(9): 1271-1273. 

[3] 李小毛 , 王佳 . 机器人手术在子宫内膜癌分期手术 中安全性与有效性的荟萃分析 [J]. 中华妇产科杂 志 , 2017, 52(3)：175-183. 

[4] Dindo D, Demartines N, Clavien P A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg, 2004, 240(2): 205-213. 

[5] 王卫杰 , 高玲玲 , 徐建波 , 等 . 达芬奇机器人手术 系统与腹腔镜手术在子宫内膜癌全面分期手术中 安全性和有效性的 Meta 分析 [J]. 中华妇幼临床医 学杂志（电子版）, 2018, 14(3)：296-304. 

[6] Guy M S, Sheeder J, Behbakht K, et al. Comparative outcomes in older and younger women undergoing laparotomy or robotic surgical staging for endometrial cancer[J]. Am J Obstet Gynecol, 2016, 214(3): 350 e351-350 e310. 

[7] Paley P J, Veljovich D S, Shah C A, et al. Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases[J]. Am J Obstet Gynecol, 2011, 204(6): 551 e551-559. 

[8] Turrentine F E, Wang H, Simpson V B, et al. Surgical risk factors, morbidity, and mortality in elderly patients[J]. J Am Coll Surgeons, 2006, 203(6): 865-877. 

[9] Gallotta V, Conte C, D'Indinosante M, et al. Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients[J]. J Minim Invas Gyn, 2018, 25(5): 872-877. 

[10] Lowe M P, Kumar S, Johnson P R, et al. Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature[J]. Journal of robotic surgery,2010, 4(2): 109-115. 

[11] Wright J D, Lewin S N, Barrena Medel N I, et al. Morbidity and mortality of surgery for endometrial cancer in the oldest old[J]. Am J Obstet Gynecol, 2011, 205(1): 66 e61-68. 

[12] Catanzarite T, Saha S, Pilecki M A, et al. Longer operative time during benign laparoscopic and robotic hysterectomy is associated with increased 30-day perioperative complications[J]. J Minim Invas Gyn, 2015, 22(6): 1049-1058. 

[13] Satoh T, Matsumoto K, Uno K, et al. Silent venous thromboembolism before treatment in endometrial cancer and the risk factors[J]. Brit J Cancer, 2008, 99(7): 1034-1039. 

[14] Wang X, Fu S, Freedman R S, et al. Venous thromboembolism syndrome in gynecological cancer[J]. Int J Gynecol Cancer, 2006, 16(Suppl 1): 458-471. 

[15] Singh S, Swarer K, Resnick K. Longer operative time is associated with increased post-operative complications in patients undergoing minimally-invasive surgery for endometrial cancer[J]. Gynecol Oncol, 2017, 147(3): 554-557. 

[16] Frey M K, Lin J F, Stewart L E, et al. Comparison of two minimally invasive approaches to endometrial cancer staging: a single-surgeon experience[J]. J Reprod Med, 2015, 60(3-4): 127-134. 

[17] 龚静 , 王楠 , 王敏 , 等 . 机器人手术治疗子宫内膜 癌合并肥胖 [J]. 中国微创外科杂志 , 2016, 16(8)： 685-688. 

[18] Gunderson C C, Java J, Moore K N, et al. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study[J]. Gynecol Oncol, 2014, 133(1): 23-27. 

[19] Bouwman F, Smits A, Lopes A, et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery-an institutional study and systematic review of the literature[J]. Gynecol Oncol, 2015, 139(2): 369-376. 

[20] Santoso J T, Barton G, Riedley-Malone S, et al. Obesity and perioperative outcomes in endometrial cancer surgery[J]. Arch Gynecol Obstet, 2012, 285(4): 1139- 1144.